Please assess the completion status of the following clinical trial:

Trial Title: NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions in Denmark

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects aged 18 years or over.~* Subjects diagnosed with peripheral neuropathic pain.~* Subjects that independently of the study and before consideration for observation in the study have been prescribed pregabalin for treatment of peripheral neuropathic pain either.~  1. for the first time ('first prescription patients') or~ 2. that have not used pregabalin within the previous 6 months but are prescribed pregabalin again ('re-treatment patients')~* Subjects that haven't taken the first dose of the prescribed pregabalin yet.~Exclusion Criteria:~* Subjects not consenting to participate.~* Subjects that at study inclusion (baseline) are on treatment with pregabalin for generalized anxiety or epilepsy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients with peripheral neuropathic pain treated with Lyrica (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).